Thomas Michael Raffay MD FAAP
Neonatal Respiratory Failure & Lung Development
Neonatologist at Rainbow Babies and Children's Hospital/Case Western Reserve University
Join to View Full Profile
11100 Euclid AveRbc Suite 3100Cleveland, OH 44106
Phone+1 216-844-3387
Fax+1 216-844-3380
Dr. Raffay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Neonatal-Perinatal Medicine, 2010 - 2013
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Ohio State University College of MedicineClass of 2007
Certifications & Licensure
OH State Medical License 2007 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Neonatal-Perinatal Medicine
Publications & Presentations
PubMed
- Unique infrared thermographic profiles and altered hypothalamic neurochemistry associated with mortality in endotoxic shock.Sean N Curtis, Catherine A Mayer, Tracey L Bonfield, Thomas M Raffay, Juliann M DiFiore
Experimental Neurology. 2025-03-01 - Predictors of mortality and severe illness from Escherichia coli sepsis in neonates.Adriana Hoffman, Sriram Satyavolu, Danah Muhanna, Sindhoosha Malay, Thomas Raffay
Journal of Perinatology. 2024-12-01 - Postnatal corticosteroid therapy in bronchopulmonary dysplasia - why animal studies disagree with clinical trials?Anantha Harijith, Thomas M Raffay, Rita M Ryan
Pediatric Research. 2024-10-01
Press Mentions
Pulmonary Hypertension Linked to Worse Bronchopulmonary Dysplasia Outcomes in InfantsNovember 16th, 2023
Grant Support
- S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lungCASE WESTERN RESERVE UNIVERSITY2024–2028
- S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lungCASE WESTERN RESERVE UNIVERSITY2024–2028
- R01 S-Nitrosoglutathione Reductase in Neonatal Hyperoxic Lung InjuryNIH NHLBI2024–2028
- Pilot Study of an Inhaled Treatment for Bronchopulmonary DysplasiaCASE WESTERN RESERVE UNIVERSITY2021–2025
- Pilot Study of an Inhaled Treatment for Bronchopulmonary DysplasiaCASE WESTERN RESERVE UNIVERSITY2021–2025
- Pilot Study of an Inhaled Treatment for Bronchopulmonary DysplasiaCASE WESTERN RESERVE UNIVERSITY2021–2025
- R03 GSNO Metabolism in Tracheal AspiratesNIH NHLBI2021–2024
- K08 S-Nitrosoglutathione in BPDNIH NHLBI2017–2023
- U01 PreVENTNIH NHLBI2016–2021
- S-Nitrosoglutathione Reductase Inhibition in PAHATS Foundation Research Award2017–2019
Professional Memberships
- Fellow
- Member
- Society for Pediatric Research - SPRMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
